CompuGroup Medical simplifies provider access to telemedicine

PHOENIX, March 20, 2020 /PRNewswire/ — CompuGroup Medical US (CGM) today announces that it has made it easier for healthcare providers to mitigate the spread of the virus using CGM ELVI Telemedicine at no charge.

Telemedicine, or telehealth, is a new healthcare platform that enables virtual consultations. When doctors can reach patients from anywhere at any time, in-office visits are no longer required, and this eliminates the risk of spreading the COVID-19 coronavirus to practice staff and other patients.

In addition to providing its CGM ELVI Telemedicine software at no charge, CGM has made it easier for providers to adopt the new system by launching a dedicated website, cgmtelehealth.com, and a dedicated phone line, +1 (602) 680-2255.

“We began offering CGM ELVI Telemedicine to providers at no cost last week, and the response to this initiative has been inspiring,” said Chief Executive Officer Benedikt Brueckle. “We knew right away that we could make things even simpler for providers by creating a dedicated website and phone line to help them get started.”

Telehealth solutions like CGM ELVI are getting a lot of attention now that Americans are practicing social distancing and avoiding crowds and public spaces.

“CGM ELVI is easy to implement,” Brueckle said. “We can get providers up and running very quickly. At CGM, we are committed towards helping boost access to telemedicine in the United States, thereby mitigating the spread of COVID-19.”

CGM ELVI Telemedicine allows providers to collect patient information; share images, vitals, and findings; provide care from anywhere at any time; initiate treatments and therapies rapidly; offer continuous care to immobile patients; and reduce the workload of practice staff—all without the risk of spreading infection.

About CompuGroup Medical

CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base, according to preliminary figures, of EUR 757 million in 2019, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1 million users, including doctors, dentists, pharmacists, lab technicians, and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company representing one of the highest coverage among eHealth service providers. More than 5,600 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

For more information regarding CompuGroup Medical, visit cgm.com/us.

CompuGroup Medical
Media Contact: Dan Doll
(855) 270-6700 x 1024
daniel.doll@cgm.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/compugroup-medical-simplifies-provider-access-to-telemedicine-301027643.html

SOURCE CompuGroup Medical

Staff

Recent Posts

The Power of Tracking: New Preliminary Data Underscores How MyFitnessPal Supports Weight Management Goals

Research highlights how nutrition tracking drives success for weight loss and health goals NEW YORK,…

1 hour ago

Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…

4 hours ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…

4 hours ago

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…

4 hours ago